Most of what goes wrong happens because "help us get into China" gets treated as a single ask. It isn't. Here's how we actually break it down — and who does each part.
Some of these modules we run ourselves. Some we hand to our specialist partners who do the on-the-ground execution. Some legally have to sit with licensed specialists — lawyers, regulatory consultants — and we don't pretend otherwise. Knowing which is which, before you start, is most of what keeps a project from going sideways.
Whether this asset is worth taking to China at all — not "can it enter," but whether Chinese capability would actually move it to its next value inflection point faster than the alternatives.
Done before the IP structure is designed, not alongside it — a red flag here can make the rest of this list irrelevant.
Where most European IP holders get exposed if this isn't done properly.
Not "a team" — a specific capability match, backed by real diligence.
The step most likely to quietly sink a project.
JRZ's role is judging whether this path is worth taking; the submission itself sits with licensed regulatory counsel.
Decided before the project starts, not renegotiated once something's gone wrong.
Capital follows the asset's proven milestones — it isn't raised upfront and pointed at a plan. JRZ doesn't raise or manage the money itself.
The part that's easiest to forget. Get this wrong at the start, and you end up with data China finished that Europe can't actually use.
Most conversations start with modules 1 and 2 — qualification and compliance screening — before anything else is worth discussing. A 30-minute call is usually enough to tell you which modules actually apply.
Book a 30-minute call